Cystectomy for muscle-invasive bladder cancer: Patterns and outcomes of care in the medicare population

A marked heterogeneity exists in the strategies used to treat muscle-invasive bladder cancer. The extent to which this variation can be attributed to the lack of informative clinical trials, the presence of comorbid illness, patient or physician preferences, or access to care warrants further evaluation.